Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chisato Nishida"'
Autor:
Chisato Nishida, Yuki Matsumoto, Katsukuni Fujimoto, Masayoshi Shirakawa, Rebecca Ellen Wrishko, Martin Otto Behm, Kenichi Furihata
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 6, Pp 704-712 (2019)
Certain patient populations are unable to achieve the recommended low‐density lipoprotein cholesterol goals with statin monotherapy alone. Such patients may benefit from concomitant therapy with ezetimibe (EZE) 10 mg added on to a statin. To this e
Externí odkaz:
https://doaj.org/article/89b029df548640068e007a2561c257cc
Autor:
Kazuhiro Hashiguchi MD, Kimihiro Okubo MD, PhD, Yoichi Inoue MD, Hirotaka Numaguchi MD, PhD, Kumi Tanaka MS, Nobuyuki Oshima MS, Anish Mehta BA, Chisato Nishida MS, Itori Saito MS, George Philip MD
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Background This study evaluated the efficacy of montelukast in reducing seasonal allergic rhinitis symptoms in Japanese children with Japanese cedar (JC) pollinosis induced in an artificial exposure chamber (OHIO Chamber). Methods Pediatric patients
Externí odkaz:
https://doaj.org/article/90d6093b7fe444c4afbf854f42e421fa
Autor:
Katsukuni Fujimoto, Rebecca E Wrishko, Yuki Matsumoto, Martin O. Behm, Chisato Nishida, Kenichi Furihata, Masayoshi Shirakawa
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 12, Iss 6, Pp 704-712 (2019)
Clinical and Translational Science, Vol 12, Iss 6, Pp 704-712 (2019)
Certain patient populations are unable to achieve the recommended low‐density lipoprotein cholesterol goals with statin monotherapy alone. Such patients may benefit from concomitant therapy with ezetimibe (EZE) 10 mg added on to a statin. To this e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d95f80aa162b50452459c50d764779f
https://doi.org/10.1111/cts.12677
https://doi.org/10.1111/cts.12677
Autor:
Yuki Matsumoto, Itori Saito, Kimihiro Okubo, Nobuyuki Oshima, Marita Prohn, Kumi Tanaka, Hirotaka Numaguchi, Chisato Nishida, George Philip, Anish Mehta, Yoichi Inoue
Publikováno v:
Journal of Drug Assessment
Background: This study was conducted to evaluate the safety and tolerability, and population pharmacokinetics (PPK) of montelukast as well as efficacy in the treatment of perennial allergic rhinitis (PAR) in paediatric Japanese patients aged between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a67840412cedf2c06aeb4d437af4a730
Autor:
Hirotaka Numaguchi, Kimihiro Okubo, Itori Saito, Kazuhiro Hashiguchi, Chisato Nishida, Yoichi Inoue, George Philip, Nobuyuki Oshima, Anish Mehta, Kumi Tanaka
Publikováno v:
Allergy & Rhinology, Vol 9 (2018)
Background This study evaluated the efficacy of montelukast in reducing seasonal allergic rhinitis symptoms in Japanese children with Japanese cedar (JC) pollinosis induced in an artificial exposure chamber (OHIO Chamber). Methods Pediatric patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973046102cef2fbdbc0c69e9f69fccab
https://doi.org/10.1177/2152656718783599
https://doi.org/10.1177/2152656718783599
Autor:
Kazuyuki Shimada, Kenji P Fujita, Hiromi Rakugi, Hiroya Yamaguchi, Hirotaka Numaguchi, Chisato Nishida, Masayoshi Shirakawa, Kyoichi Azuma, Takuya Tsuchihashi
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 37(3)
Japanese patients with uncontrolled essential hypertension received single-blind losartan 50 mg/hydrochlorothiazide 12.5 mg (L50/H12.5) for 8 weeks. Patients whose blood pressure (BP) remained uncontrolled were randomized double-blind to fixed-dose l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc3329490853b5ab38b095eadb1ad59
https://pubmed.ncbi.nlm.nih.gov/25271811
https://pubmed.ncbi.nlm.nih.gov/25271811
Autor:
Hiroya Yamaguchi, Takuya Tsuchihashi, Hirotaka Numaguchi, Chisato Nishida, Kenji P Fujita, Masayoshi Shirakawa, Kyoichi Azuma, Hiromi Rakugi, Kazuyuki Shimada
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 38(5)
This study assessed the antihypertensive efficacy of a triple combination, fixed-dose therapy of losartan 50 mg (L50)/hydrochlorothiazide 12.5 mg (H12.5)/amlodipine 5 mg (A5) versus co-administration of L50 plus A5 (L50+A5) in Japanese subjects with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aabf48eaf37589fd4989c87f099a3794
https://pubmed.ncbi.nlm.nih.gov/25716649
https://pubmed.ncbi.nlm.nih.gov/25716649
Autor:
Hiroya Yamaguchi, Takuya Tsuchihashi, Go Fujimoto, Hirotaka Numaguchi, Chisato Nishida, Kenji P Fujita, Hiromi Rakugi, Kyoichi Azuma, Mary E. Hanson, Masayoshi Shirakawa, Kazuyuki Shimada
Publikováno v:
Hypertension research : official journal of the Japanese Society of Hypertension. 37(12)
Two randomized studies were designed to assess the safety, tolerability and efficacy of losartan 100 mg (L100) plus hydrochlorothiazide 12.5 mg (H12.5) in a single fixed-dose combination. In one study, subjects received losartan 50 mg (L50) plus H12.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bdb8dcc723d7a108b5fb830fae338ab
https://pubmed.ncbi.nlm.nih.gov/25185832
https://pubmed.ncbi.nlm.nih.gov/25185832
Autor:
Mary E. Hanson, Takuya Tsuchihashi, Kenji P Fujita, Go Fujimoto, Kazuyuki Shimada, Hiromi Rakugi, Hirotaka Numaguchi, Chisato Nishida, Masayoshi Shirakawa, Hiroya Yamaguchi, Kyoichi Azuma
Publikováno v:
Hypertension Research. 37:1088-1088
Correction to: Hypertension Research (2014) 37, 1042–1049; doi:10.1038/hr.2014.114; published online 3 July 2014 The authors of the above paper noticed an error in publication (AOP). ‘Mean (±s.e.) change from baseline’ scale of Figure 3 was th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4adbc234fa84698456ee9b9e799206c1
https://doi.org/10.1038/hr.2014.147
https://doi.org/10.1038/hr.2014.147